Showing results (1591-1600 of 5,543) with videos related to
Sort By:
Pageof 555
Journal of Cancer|September 19, 2019
Wnt3a protein overexpression predicts worse overall survival in laryngeal squamous cell carcinomaDiekuo Zhang, Guo Li, Xiyu Chen, et al.Journal of Cancer|September 19, 2019
Adverse Effect of Lymph Node Dissection in Metastatic Renal Cell Cancer Patients Treated with Cytoreductive Nephrectomy: A Contemporary Analysis of SurvivalDalong Cao, Yongqiang Huang, Chuankai Zhang, et al.Journal of Cancer|April 30, 2025
MiR-371b-5p reduces osteosarcoma cell migration and proliferation to induce apoptosis by targeting FUT4Qiang Xue, Ruicong Ma, YueYuan Chen, et al.Journal of Cancer|April 30, 2025
HPV Genotype, AGC Categories, and Age-Stratified Immediate Prevalence of Precancers and Cancers in Women with Atypical Glandular Cells with or without Concurrent Squamous Abnormal CytologyXin Zhou, Zicheng Huang, Wanrun Lin, et al.Journal of Cancer|April 30, 2025
circ_0046599 Promotes HCC Progression by Competing with miR-1322 to Enhance NT5DC2 ExpressionXiaobo Zhang, Suxin Li, Luhao Li, et al.Journal of Cancer|April 30, 2025
Arachidonic acid promotes myeloid differentiation of splenic CD45- Ter119+ cells in myeloproliferative neoplasmLinlin Zhang, Yi Yang, Xiao Yu, et al.Journal of Cancer|June 19, 2025
Pan-cancer analysis identifies DBF4B as an immunologic and prognostic biomarkerChongjiu Qin, Yu Chen, Haifei Qin, et al.Journal of Cancer|January 26, 2026
Hypoxia-Driven Immune Escape in Clear Cell Renal Cell Carcinoma: A Prognostic Model and Dual-Functional Biomarker PLOD2 for Immunotherapy StratificationFei Xiao, Yi Guan, Huajie Song, et al.Journal of Cancer|January 26, 2026
Single-cell and transcriptomic profiling reveal stemness-driven immune evasion in obstructive sleep apnea (OSA) associated lung cancerYu-Wei Liu, Chi-Jen Wu, Kai-Fu Chang, et al.Journal of Cancer|January 26, 2026
Spatial Profiling and Prognostic Role of Tumor-Infiltrating CD8+ T and CD20+ B Cells in Metastatic Clear Cell Renal Cell Carcinoma Treated with Sequential Tyrosine Kinase Inhibitors and NivolumabAndriy Trailin, Lenka Červenková, Petr Hošek, et al.Pageof 555